content

FDA Approves Galafold for the Treatment of Certain Adult Patients with Fabry Disease

Amicus Therapeutics announced that the U.S. FDA has granted accelerated approval of Galafold™ (migalastat) 123 mg capsules. Galafold is an oral, precision medicine for...

Artificial enzyme: Protein designed entirely from scratch functions in cells as a life-sustaining catalyst

A dawning field of research, artificial biology, is working toward creating a genuinely new organism. At Princeton, chemistry professor Michael Hecht and the researchers...

Vetter Works Towards a Sustainable Energy Supply

Vetter, a global operating Contract Development and Manufacturing Organization (CDMO) has reached another important milestone regarding sustainability. Beginning immediately, all German...

Design Contract For UK’s First VMIC Won By WHP

The development of the UK’s first dedicated Vaccines Manufacturing Innovation Centre (VMIC) has moved a step closer with the contract to design an advanced...

Pharmatag 2019: Liquid Pharmaceuticals in the Digital age

Following the motto "Expertise for the perfect flow", Bosch Packaging Technology Crailsheim hosted its Pharmatag 2019. 300 international participants accepted the invitation to the...

Dorian Therapeutics Accesses Novel Compound Library From Ubiquigent

Ubiquigent Limited, a company focused on enabling and supporting ubiquitin system-focused drug discovery, announced that it had entered into an agreement with Dorian Therapeutics...

CPhI China opens with analysis pointing to a surge in growth in 2019

New analysis released ahead of CPhI & P-MEC China (#CPhIChina and #PMECChina) – co-organized by Informa Markets, CCCMHPIE, and Shanghai Sinoexpo Informa Markets –...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from up to 5 devices at once

Must read